10
Participants
Start Date
August 31, 2007
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
somatropin [rDNA origin] for injection
Genotropin will be started at 0.3 mg/kg/week administered by daily subcutaneous injection. Doses will be increased by weight at each visit. Additionally, we will monitor IGF-1 levels at month 3, and 6 and adjust the Genotropin dose to maintain IGF-1 levels in the 50th -75th percentile for ages.
Columbus Children's Hospital, Columbus
Collaborators (1)
Pfizer
INDUSTRY
Nationwide Children's Hospital
OTHER